Canola oil and fatty liver disease is a topic of growing interest among patients seeking dietary strategies to support liver health. Fatty liver disease, or hepatic steatosis, affects approximately one in three UK adults and is closely linked to diet, obesity, and metabolic health. Whilst some animal studies have raised questions about high omega-6 fatty acid intake, there is no established clinical evidence linking moderate rapeseed (canola) oil consumption to fatty liver development in humans. This article examines the relationship between canola oil and fatty liver, reviews the nutritional profile of rapeseed oil, and provides evidence-based dietary guidance aligned with NICE and UK specialist recommendations for managing hepatic steatosis.

What Is Fatty Liver Disease and How Does Diet Affect It?

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells—defined as ≥5% of hepatocytes containing fat (or liver fat fraction >5% on imaging). The condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD), which affects individuals who consume little to no alcohol, and alcoholic fatty liver disease (AFLD), directly linked to excessive alcohol intake. NAFLD has become increasingly prevalent in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome. Some clinical guidelines now use the term metabolic dysfunction-associated steatotic liver disease (MASLD) to reflect the underlying metabolic drivers.

The liver plays a crucial role in metabolising dietary fats, carbohydrates, and proteins. When the balance between fat intake, synthesis, and elimination becomes disrupted, triglycerides accumulate within hepatocytes. This process can progress from simple steatosis to non-alcoholic steatohepatitis (NASH), characterised by inflammation and cellular damage, potentially advancing to fibrosis, cirrhosis, or hepatocellular carcinoma if left unmanaged.

Dietary factors significantly influence fatty liver development and progression. Excessive calorie intake, particularly from refined carbohydrates and added sugars (especially fructose), promotes hepatic fat accumulation. The type and quality of dietary fats consumed may also play a role, though overall dietary pattern and energy balance are more important than individual nutrients. Some animal studies suggest that diets very high in omega-6 polyunsaturated fatty acids (PUFAs) relative to omega-3 PUFAs might promote inflammatory pathways, but human evidence is limited and UK guidance does not recommend specific omega-6 to omega-3 ratio targets.

NICE guidance (NG49) emphasises lifestyle modification as the cornerstone of NAFLD management, recommending weight reduction and increased physical activity. Evidence from specialist guidelines suggests that gradual weight loss of 5–10% of body weight can improve liver fat, with 7–10% loss potentially benefiting inflammation in NASH. Understanding how dietary components, including cooking oils, fit within a balanced eating pattern enables patients to make informed nutritional choices that support hepatic function and overall metabolic health.

Rapeseed (Canola) Oil: Nutritional Profile and Health Properties

Rapeseed oil, known as canola oil in some countries, is derived from specially bred rapeseed varieties (Brassica napus) and has become one of the most widely consumed cooking oils in the UK. The term 'canola' denotes 'Canadian oil, low acid', referring to cultivars containing less than 2% erucic acid and low levels of glucosinolates, distinguishing it from traditional rapeseed oil which contained higher levels of these compounds.

The nutritional composition of rapeseed (canola) oil includes:

• Monounsaturated fatty acids (MUFAs): Approximately 61–65%, predominantly oleic acid (omega-9)

• Polyunsaturated fatty acids (PUFAs): Approximately 28–32%, including linoleic acid (omega-6, ~20%) and alpha-linolenic acid (omega-3, ~9–11%)

• Saturated fatty acids: Approximately 7%, among the lowest of common cooking oils

• Vitamin E: Provides tocopherols with antioxidant properties

Rapeseed oil's fatty acid profile offers potential cardiovascular benefits, as MUFAs and a relatively balanced omega-6 to omega-3 ratio (approximately 2:1) may support healthier lipid profiles. Refined rapeseed oil remains stable at moderate to high cooking temperatures, making it suitable for various culinary applications including sautéing, roasting, baking, and salad dressings. Cold-pressed rapeseed oil has a lower smoke point and is best reserved for dressings or low-to-medium heat cooking.

However, concerns regarding rapeseed oil and liver health have emerged in some research contexts. Animal studies have suggested that very high omega-6 PUFA intake, particularly when the omega-6 to omega-3 ratio is markedly imbalanced, may promote hepatic inflammation and oxidative stress. Additionally, the industrial processing of rapeseed oil—including heating, bleaching, and deodorisation—can theoretically generate small amounts of trans fats and oxidised lipid products. In practice, reputable UK producers maintain trans fat levels well within legal limits; industrial trans fats are very low in the UK diet, and the EU limit of 2% industrial trans fats in food applies in Northern Ireland under retained EU law, with industry reduction measures in place across Great Britain under Food Standards Agency (FSA) oversight.

It is important to note that there is no established clinical link between moderate rapeseed oil consumption and fatty liver disease development in humans. Most evidence suggesting potential harm derives from animal models using excessive quantities not reflective of typical human dietary patterns. UK dietary guidance does not recommend restricting omega-6 intake; rather, it emphasises overall dietary quality, energy balance, and replacing saturated fats with unsaturated fats.

Evidence-Based Dietary Recommendations for Fatty Liver

NICE guidance (NG49) and current evidence support comprehensive dietary strategies for managing fatty liver disease, focusing on overall dietary patterns rather than single nutrients or foods. The Mediterranean diet consistently demonstrates the strongest evidence base for improving hepatic steatosis, characterised by abundant vegetables, fruits, whole grains, legumes, nuts, olive oil as the primary fat source, moderate fish consumption, and limited red meat and processed foods.

Key evidence-based dietary principles for fatty liver management include:

• Calorie restriction: Achieving a sustainable energy deficit (typically around 600 kcal/day, in line with NICE obesity guidance) to promote gradual weight loss. Evidence shows that 5–10% body weight reduction can significantly decrease hepatic fat content, with 7–10% loss potentially improving inflammation in NASH according to specialist guidelines (BSG, EASL).

• Reduced refined carbohydrates and added sugars: Limiting free sugars, particularly fructose-containing beverages, sweets, and processed foods that promote de novo lipogenesis (fat synthesis in the liver), in line with SACN recommendations.

• Increased dietary fibre: Consuming 25–30 g daily from vegetables, fruits, whole grains, and legumes to improve insulin sensitivity and reduce hepatic inflammation.

• Quality protein intake: Incorporating lean proteins, fish, and plant-based sources to support liver regeneration whilst limiting excessive red and processed meat.

• Omega-3 fatty acids: Consuming oily fish (such as salmon, mackerel, sardines) twice weekly provides EPA and DHA. Evidence on omega-3 supplements for NAFLD is mixed, and high-dose supplementation (2–4 g EPA/DHA daily) is not routinely recommended by NICE. Patients considering supplements should discuss this with their GP.

Regarding cooking oils and dietary fats, current evidence supports:

• Replacing saturated fats (butter, lard, coconut oil) with unsaturated fats, in line with SACN guidance on saturated fats.

• Prioritising extra virgin olive oil, which contains polyphenols with anti-inflammatory and antioxidant properties.

• Limiting total fat intake to 25–35% of daily calories, emphasising quality over quantity.

• Avoiding trans fats entirely, found in some processed and fried foods.

Patients should avoid restrictive or extreme diets lacking scientific support. The British Liver Trust recommends sustainable, balanced approaches that can be maintained long-term. Those with confirmed NAFLD should be referred to a registered dietitian for personalised nutritional counselling, particularly if diabetes, dyslipidaemia, or other metabolic conditions coexist.

UK primary care pathway for NAFLD includes:

• Risk stratification using FIB-4 or NAFLD Fibrosis Score to assess likelihood of advanced fibrosis.

• If indeterminate risk, arrange Enhanced Liver Fibrosis (ELF) blood test.

• Refer to hepatology if advanced fibrosis is suspected or confirmed.

• Note that normal liver function tests do not exclude NAFLD or advanced fibrosis; imaging or non-invasive fibrosis assessment (such as FibroScan) may be required.

Alcohol guidance: Patients with NAFLD should adhere to UK Chief Medical Officers' low-risk drinking guidelines (no more than 14 units per week, spread over 3+ days). Those with evidence of liver damage should consider abstinence and discuss alcohol intake with their GP.

When to seek urgent medical advice: Contact your GP promptly or attend A&E if you experience jaundice (yellowing of skin or eyes), abdominal swelling (ascites), confusion or altered mental state, vomiting blood, or black tarry stools, as these may indicate serious liver complications requiring urgent assessment.

Healthier Cooking Oil Alternatives for Liver Health

For individuals concerned about liver health or managing fatty liver disease, selecting appropriate cooking oils represents one component of a comprehensive dietary strategy. Whilst no single oil causes or cures fatty liver disease, certain options offer nutritional advantages that align with evidence-based recommendations for hepatic health.

Extra virgin olive oil (EVOO) is the most extensively studied oil in the context of liver health, primarily within Mediterranean diet research. EVOO contains high levels of oleic acid (MUFA) and bioactive polyphenols including hydroxytyrosol and oleuropein, which demonstrate anti-inflammatory and antioxidant properties. Small clinical trials and observational studies suggest that EVOO consumption, as part of a Mediterranean dietary pattern, may help reduce liver enzyme elevations, decrease hepatic steatosis, and improve insulin sensitivity. EVOO is generally stable at typical home cooking temperatures due to its antioxidant content. For optimal benefit, choose cold-pressed, extra virgin varieties and use for low-to-medium heat cooking, dressings, and finishing dishes.

Avocado oil provides a similar fatty acid profile to olive oil, with approximately 70% MUFAs, and possesses a higher smoke point (approximately 270°C), making it suitable for higher-temperature cooking methods. It contains lutein and other carotenoids with antioxidant properties, though it lacks the extensive research base supporting olive oil.

Walnut oil and flaxseed oil offer high alpha-linolenic acid (ALA) content, a plant-based omega-3 fatty acid. These oils should be used unheated in dressings or drizzled over finished dishes, as they oxidise readily when heated. Whilst ALA provides some anti-inflammatory benefits, conversion to EPA and DHA (the more bioactive omega-3 forms) is limited in humans.

Refined rapeseed oil can be used in moderation as part of a varied diet, particularly for higher-heat cooking where olive oil may not be preferred. Cold-pressed rapeseed oil has a lower smoke point and is better suited to dressings or low-to-medium heat cooking. Choosing reputable UK producers ensures minimal processing-related concerns.

Oils to limit for liver health, in line with UK guidance on saturated fats, include:

• Coconut oil: Contains approximately 90% saturated fat. SACN recommends limiting saturated fat intake; whilst coconut oil can be used occasionally, it should not replace unsaturated oils as the primary cooking fat.

• Palm oil: High in saturated fat and often found in processed foods.

• Partially hydrogenated oils: Contain trans fats linked to inflammation and metabolic dysfunction; these are rare in the UK food supply due to industry reduction efforts and regulatory oversight by the FSA.

Practical recommendations include using oils sparingly (even healthy options are calorie-dense at 9 kcal/g), varying oil types to obtain diverse nutrients, storing oils in cool, dark places to prevent oxidation, and prioritising whole food fat sources such as nuts, seeds, avocados, and oily fish alongside cooking oils. Patients should remember that overall dietary pattern, calorie balance, and lifestyle factors exert far greater influence on liver health than any single food or oil choice.

If you experience side effects from any dietary supplement or medicine, report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or by searching for 'Yellow Card' in the Google Play or Apple App Store.

Frequently Asked Questions